New Delhi: The Serum Institute of India (SII) has urged the Union health ministry to allow in-house testing of its Cy-Tb injection for the detection of latent tuberculosis, saying the testing facility for this product is not available in any government lab in the country, official sources said on Wednesday.
A letter in this regard was written by Prakash Kumar Singh, Director at SII, they said. The Drugs Controller General of India (DCGI) approved market authorisation of Cy-Tb injection on May 9, 2022, but even after a year of approval, Cy-Tb is not available in the market due to the non-availability of testing facility in any government lab in India, Singh said in the letter.
